Palantir Insiders Selling Shares Spur Defense Stock Bets
Insider trading patterns at Palantir raise questions about the stock's growth path as defense sector stocks attract c...
A clear look at the stablecoins that outperformed peers this year, with insights into drivers and risk considerations for future allocations.
26,211 articlesInsider trading patterns at Palantir raise questions about the stock's growth path as defense sector stocks attract c...
Lime’s IPO plans put micro-mobility in the spotlight. This article explains why a seasoned investor might prefer an e...
A large fund sold a sizable stake, and the stock still lagged the market. This look breaks down what happened, why it...
MortgageOne TPO announces an ARIVE integration alongside the Pathway CDFI loan program, aiming to broaden homeownersh...
A wave of upgrades is reshaping Near Protocol. Privacy features, AI-ready smart contracts, and scaling improvements c...
A CEO’s drastic HR purge and a high-profile EEOC lawsuit against The New York Times collide at a moment of market vol...
CVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
When high-profile relationships hit a rough patch, money matters quietly shape the outcome. This piece digs into what...
Bitcoin stays above a key $73,000 support zone as analysts debate whether the level can ignite a summer rally. If buy...
Mid‑level professionals eyeing Portugal as a retirement destination must navigate rising taxes and housing costs. Thi...
XRP stands at a crucial juncture as traders debate whether a wick or brick pattern will define the next macro move. P...
A Ligand Pharmaceuticals insider recently sold 5,000 shares, triggering discussions about what insider moves signal f...